EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Membrane‐Active Peptide Protects Against Inflammation by Targeting NLRP3 Activation at the Trans‐Golgi Network

Jonas Engelhardt, Nico Kirsch iD, Aileen Kerfin, Lars P Lunding iD, Dominic Ferber iD, Hannes Buthmann iD, Ilka Schreier, Carlotta Bosio, Ann-Kathrin Dobbelstein, Anna Klawonn, Rebecca C Coll iD, Lena Bauernhofer iD and 5 more

Advanced Science · 2026

DOI: 10.1002/advs.76587 ↗

At a glance

Journal article in Advanced Science, 2026. Written by Jonas Engelhardt and 16 co-authors. Institution: Pharmaceutical Institute, Section Pharmacology and Toxicology, University of Bonn, Bonn, Germany. Major MEDLINE topics: NLR Family, Pyrin Domain-Containing 3 Protein, trans-Golgi Network, Inflammation, Inflammasomes. 71 references. The full text is freely available (open access, CC BY 4.0). Funded by: Deutsche Forschungsgemeinschaft (DFG, German Research Foundation), European Research Council (ERC Advanced Grant), Leibniz Research Alliance 'Leibniz Health Technologies'.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

The NLRP3 inflammasome is a multi‐protein complex that plays a crucial role in inflammatory processes mediated by the innate immune system. Dysregulated NLRP3 activation has been implicated in age‐related inflammatory diseases, making it a promising therapeutic target. Here, we report that the synthetic membrane‐active antimicrobial peptide Pep19‐2.5 directly inhibits NLRP3 inflammasome activation. Through cellular, biophysical, and biochemical analyses, we find that Pep19‐2.5 suppresses NLRP3 inflammasome signaling downstream of NLRP3 activation. Pep19‐2.5 interacts with macrophage membranes, supporting a membrane‐targeting mechanism for its anti‐inflammatory effects. Mechanistically, Pep19‐2.5 binds to phosphatidylinositol (PI)‐containing lipid membranes and dispersed trans‐Golgi network (dTGN) structures, which could potentially affect NLRP3 recruitment to the dTGN. We demonstrate a strong and NLRP3‐dependent induction of IL‐1β secretion from human macrophages by house dust mite (HDM) extract, which can be inhibited by Pep19‐2.5. In line with these findings, therapeutic application of Pep19‐2.5 via the nasal aerosol route reduces IL‐1β levels, eosinophil infiltration in bronchoalveolar lavage and significantly improved lung function in an in vivo HDM‐mouse model of allergic airway inflammation. Our findings highlight the therapeutic potential of targeting NLRP3 activation by the small membrane‐active peptide Pep19‐2.5 for the treatment of NLRP3‐driven inflammatory diseases.

Subjects

MeSH terms (MEDLINE)

NLR Family, Pyrin Domain-Containing 3 Proteintrans-Golgi NetworkInflammationInflammasomesPeptidesAnimalsMiceHumansMacrophagesInterleukin-1beta

Author keywords

NLRP3 inflammasomePep19‐2.5allergic airway inflammationasthmainterleukin‐1betamembrane‐active peptide

Substances

NLR Family, Pyrin Domain-Containing 3 ProteinInflammasomesPeptidesInterleukin-1betaNLRP3 protein, human

Authors and institutions

  • Pharmaceutical Institute, Section Pharmacology and Toxicology, University of Bonn, Bonn, Germany.
  • Division of Immunobiophysics, Priority Area Infections, Research Center Borstel, Leibniz Lung Center, Member of Leibniz Health Technologies, Borstel, Germany.
  • Division of Lung Immunology, Priority Area Chronic Lung Diseases, Research Center Borstel, Leibniz Lung Center, Borstel, Germany.
  • Airway Research North (ARCN), German Center for Lung Research (DZL), Borstel, Germany.
  • Institute of Structural Biology, University of Bonn, Bonn, Germany.
  • Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, UK.

ORCID profiles: Nico Kirsch, Lars P Lunding, Dominic Ferber, Hannes Buthmann, Rebecca C Coll, Lena Bauernhofer, Sandro Keller, Matthias Geyer, Michael Wegmann, Andra B Schromm, Günther Weindl

Funding

  • Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)
  • European Research Council (ERC Advanced Grant)
  • Leibniz Research Alliance 'Leibniz Health Technologies'
  • Studienstiftung des deutschen Volkes, Bonn, Germany

Cite

APA

Engelhardt, J., Kirsch, N., Kerfin, A., Lunding, L. P., Ferber, D., Buthmann, H., Schreier, I., Bosio, C., Dobbelstein, A. K., Klawonn, A., Coll, R. C., Bauernhofer, L., Keller, S., Geyer, M., Wegmann, M., Schromm, A. B., & Weindl, G. (2026). Membrane‐Active Peptide Protects Against Inflammation by Targeting NLRP3 Activation at the Trans‐Golgi Network. Advanced Science. https://doi.org/10.1002/advs.76587

Vancouver

Engelhardt J, Kirsch N, Kerfin A, Lunding LP, Ferber D, Buthmann H, et al. Membrane‐Active Peptide Protects Against Inflammation by Targeting NLRP3 Activation at the Trans‐Golgi Network. Advanced Science. 2026. doi:10.1002/advs.76587

BibTeX
@article{Engelhardt2026,
  author = {Engelhardt, Jonas and Kirsch, Nico and Kerfin, Aileen and Lunding, Lars P and Ferber, Dominic and Buthmann, Hannes and Schreier, Ilka and Bosio, Carlotta and Dobbelstein, Ann-Kathrin and Klawonn, Anna and Coll, Rebecca C and Bauernhofer, Lena and Keller, Sandro and Geyer, Matthias and Wegmann, Michael and Schromm, Andra B and Weindl, Günther},
  title = {Membrane‐Active Peptide Protects Against Inflammation by Targeting NLRP3 Activation at the Trans‐Golgi Network},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.76587}
}
Start for free →